Naylor Stuart
- SEC CIK
- 0001742771
In the past year, 2 open-market sale filings worth $668.4K and no purchases.
Current role at each company
- MGTX MeiraGTx Holdings plcCHIEF SCI OFCR, OPHTHALMOLOGYas of Jul 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $668.4K
- 2 filings
- Net
- −$668.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Naylor Stuart as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 (view filing)9:05 PM ET | Jul 7 | Same day | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | SSale | −27.7K | $14.80 | −$409.5K | −4.1%640.8K after | 2 lots10b5-1 |
| Apr 7, 2026 (view filing) | Apr 7 | Same day | Naylor StuartCHIEF DEV. OFFICER | SSale | −27.7K | $9.36 | −$258.9K | −4.0%668.5K after | 10b5-1 |
| Oct 20, 2021 (view filing) | Oct 18 | 2 days | Naylor StuartChief Development Officer | SSale | −12.0K | $17.95 | −$215.4K | −2.9%402.0K after | |
| Jul 21, 2021 (view filing) | Jul 20 | 1 day | Naylor StuartChief Development Officer | SSale | −9.39K | $15.06 | −$141.4K | −2.2%414.0K after | |
| Jul 15, 2021 (view filing) | Jul 13 | 2 days | Naylor StuartChief Development Officer | SSale | −2.61K | $15.04 | −$39.3K | −0.6%423.4K after |